Cargando…

Cell and small animal models for phenotypic drug discovery

The phenotype-based drug discovery (PDD) approach is re-emerging as an alternative platform for drug discovery. This review provides an overview of the various model systems and technical advances in imaging and image analyses that strengthen the PDD platform. In PDD screens, compounds of therapeuti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szabo, Mihaly, Svensson Akusjärvi, Sara, Saxena, Ankur, Liu, Jianping, Chandrasekar, Gayathri, Kitambi, Satish S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500539/ https://www.ncbi.nlm.nih.gov/pubmed/28721015 http://dx.doi.org/10.2147/DDDT.S129447

Ejemplares similares

Stem cells: a model for screening, discovery and development of drugs
por: Kitambi, Satish Srinivas, et al.
Publicado: (2011)

Phenotypic Screening Identifies Synergistically Acting Natural Product Enhancing the Performance of Biomaterial Based Wound Healing
por: Sivasubramanian, Srinivasan, et al.
Publicado: (2017)

Phenotypic Screen Identifies a Small Molecule Modulating ERK2 and Promoting Stem Cell Proliferation
por: Yin, Chang, et al.
Publicado: (2017)

Understanding cytoskeleton regulators in glioblastoma multiforme for therapy design
por: Masoumi, Samaneh, et al.
Publicado: (2016)

Leprosy-associated Chronic Wound Management Using Biomaterials
por: Sivasubramanian, Srinivasan, et al.
Publicado: (2018)

Biological Aging in People Living with HIV on Successful Antiretroviral Therapy: Do They Age Faster?
por: Akusjärvi, Sara Svensson, et al.
Publicado: (2023)

Role of animal models in oncology drug discovery
por: Kumar, R
Publicado: (2003)

Development and validation of small animal models for onchocerciasis and loiasis microfilaricide discovery
por: Ayiseh, Rene Bilingwe, et al.
Publicado: (2023)

Genome-scale metabolic models for natural and long-term drug-induced viral control in HIV infection
por: Ambikan, Anoop T, et al.
Publicado: (2022)

Expression profile of Epstein-Barr virus and human adenovirus small RNAs in tonsillar B and T lymphocytes
por: Assadian, Farzaneh, et al.
Publicado: (2017)

Phenotypic Fingerprinting of Small Molecule Cell Cycle Kinase Inhibitors for Drug Discovery
por: Low, Jonathan, et al.
Publicado: (2009)

New drug discovery of cardiac anti-arrhythmic drugs: insights in animal models
por: Sharma, Ashish Kumar, et al.
Publicado: (2023)

Characterization of Inducible Transcription and Translation-Competent HIV-1 Using the RNAscope ISH Technology at a Single-Cell Resolution
por: Zhang, Wang, et al.
Publicado: (2018)

Chromatin maturation of the HIV-1 provirus in primary resting CD4(+) T cells
por: Lindqvist, Birgitta, et al.
Publicado: (2020)

Recent advances in phenotypic drug discovery
por: Swinney, David C., et al.
Publicado: (2020)

Leishmania Animal Models Used in Drug Discovery: A Systematic Review
por: van der Ende, Jacob, et al.
Publicado: (2023)

Small molecule screening platform for assessment of cardiovascular toxicity on adult zebrafish heart
por: Kitambi, Satish Srinivas, et al.
Publicado: (2012)

The Oncopig Cancer Model as a Complementary Tool for Phenotypic Drug Discovery
por: Segatto, Natalia V., et al.
Publicado: (2017)

Inaugural Charles River World Congress on Animal Models in Drug Discovery and Development
por: Berzofsky, Jay A., et al.
Publicado: (2017)

An Ago2-associated capped transcriptional start site small RNA suppresses adenovirus DNA replication
por: Kamel, Wael, et al.
Publicado: (2017)

Animal Models of Inflammation for Screening of Anti-inflammatory Drugs: Implications for the Discovery and Development of Phytopharmaceuticals
por: Patil, Kalpesh R., et al.
Publicado: (2019)

Synthesis, Structure, and Function of Human Adenovirus Small Non-Coding RNAs
por: Punga, Tanel, et al.
Publicado: (2020)

Machine learning-powered antibiotics phenotypic drug discovery
por: Zoffmann, Sannah, et al.
Publicado: (2019)

Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling
por: Akusjärvi, Sara Svensson, et al.
Publicado: (2021)

An optimized small animal tumour model for experimentation with low energy protons
por: Beyreuther, Elke, et al.
Publicado: (2017)

Biomolecular NMR: a chaperone to drug discovery
por: Betz, Marco, et al.
Publicado: (2006)

Systems Pharmacology in Small Molecular Drug Discovery
por: Zhou, Wei, et al.
Publicado: (2016)

C. elegans as an in vivo model system for the phenotypic drug discovery for treating paraquat poisoning
por: Ji, Peng, et al.
Publicado: (2022)

Animal Models of Neurodegenerative Disease: Recent Advances in Fly Highlight Innovative Approaches to Drug Discovery
por: Tello, Judith A., et al.
Publicado: (2022)

Preclinical Animal Models for Dravet Syndrome: Seizure Phenotypes, Comorbidities and Drug Screening
por: Griffin, Aliesha, et al.
Publicado: (2018)

Repurposing Drugs in Small Animal Oncology
por: Giuliano, Antonio, et al.
Publicado: (2022)

Reporters of Cancer Stem Cells as a Tool for Drug Discovery
por: Mohan, Amrutha, et al.
Publicado: (2021)

DrSim: Similarity Learning for Transcriptional Phenotypic Drug Discovery
por: Wei, Zhiting, et al.
Publicado: (2022)

Next Generation Sequencing: Potential and Application in Drug Discovery
por: Yadav, Navneet Kumar, et al.
Publicado: (2014)

Establishment of drug-resistant HBV small-animal models by hydrodynamic injection
por: Cheng, Junjun, et al.
Publicado: (2014)

Accelerating glioblastoma drug discovery: Convergence of patient-derived models, genome editing and phenotypic screening
por: O'Duibhir, Eoghan, et al.
Publicado: (2016)

Zebrafish as an Animal Model for Drug Discovery in Parkinson’s Disease and Other Movement Disorders: A Systematic Review
por: Vaz, Rita L., et al.
Publicado: (2018)

Adenovirus VA RNAI Blocks ASC Oligomerization and Inhibits NLRP3 Inflammasome Activation
por: Darweesh, Mahmoud, et al.
Publicado: (2019)

The Role of Small- or Medium-Sized Enterprises in Drug Discovery
por: Newton, C.G.
Publicado: (2007)

Barriers to Small Molecule Drug Discovery for Systemic Amyloidosis
por: Morgan, Gareth J.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_glla05orfshh8v0126uovm35vu